AUS
NZ
UK
CA
USA
IND
Highlights
- Total revenue growth of 42% year-over-year for Q4 2024, reaching $44.8 million.
- Adjusted EBITDA for Q4 2024 exceeded 6% of total revenue, signaling operational strength.
- Full-year revenue surged 32%, totaling approximately $159.3 million.
Kits Eyecare Ltd. (TSX:KITS), a leading vertically integrated eyecare provider, has released its preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2024. The Company reported impressive growth across various key metrics, underscoring its robust business model and strategic initiatives.
Fourth Quarter 2024 Performance
Kits Eyecare's total revenue for Q4 2024 surged by 42% year-over-year, amounting to approximately $44.8 million. This growth was driven primarily by a significant increase in glasses revenue, which accelerated by an impressive 60% year-over-year. This boost in revenue highlights the Company's successful efforts to expand its market presence and improve product offerings.
In terms of profitability, adjusted EBITDA for the fourth quarter exceeded 6% of total revenue, showing a year-over-year improvement. This indicates that Kits Eyecare has effectively managed its costs and capitalized on operational efficiencies, enhancing its bottom line. Additionally, the Company maintained a strong cash position, reporting $19.3 million in cash reserves, which ensures liquidity and provides flexibility for future investments and growth opportunities.
Full Year 2024 Overview
For the full year 2024, Kits Eyecare posted a 32% year-over-year growth in total revenue, reaching approximately $159.3 million. The strong annual performance reflects the Company’s ability to capture market share and deliver innovative eyecare products to a broad customer base.
Adjusted EBITDA for the year exceeded 4% of revenue, marking a solid improvement from the previous year. The Company’s operational efficiency and focus on margin expansion were key contributors to this positive financial outcome.
Strategic Outlook
Looking forward, Kits Eyecare is preparing to release its audited fourth-quarter and full-year results in early March 2025. The Company will also disclose details for its upcoming fourth-quarter conference call in February, providing further insights into its performance and future plans.
Kits Eyecare’s leadership in the eyecare sector, bolstered by strong revenue growth, operational discipline, and a healthy cash position, positions the Company well for continued expansion in 2025 and beyond. With an accelerated focus on its glasses segment and expanding its vertically integrated platform, KITS is well on track to build upon its success and deliver long-term shareholder value.
As the eyecare industry continues to evolve, Kits Eyecare remains committed to leveraging its technology-driven approach to redefine the customer experience while driving sustainable growth.
